The B case describes the events – including the offers and the negotiation – leading up to Sundown’s acquisition of Cyna for US$40.50 per share in cash or US$624 million (approximately C$841 million) – a 120% premium over the closing price of just over US$18 a share before the deal was announced. The case also brings the reader up to date on the turns Anthony’s life has taken since the acquisition and some of the exciting ventures in which he is now involved.
Cyna Pharma: Reaping the rewards of perseverance (A)
Summary
The A case tells the story of Anthony Giovinazzo’s entrepreneurial journey with Cyna Pharma, which he built from the ground up. Cyna Pharma was a C...
Reference
IMD-7-2316
Copyright
©2022
Copyright owner
IMD Copyright
Organization
Cyna Pharma (Disguised)
Industry
Healthcare, Biopharmaceuticals
Available Languages
English
Contact
Research Information & Knowledge Hub for additional information on IMD publications
Cyna Pharma: Reaping the rewards of perseverance (B)
Summary
The B case describes the events – including the offers and the negotiation – leading up to Sundown’s acquisition of Cyna for US$40.50 per share in ...
Reference
IMD-7-2317
Copyright
©2022
Copyright owner
IMD Copyright
Organization
Cyna Pharma (Disguised)
Industry
Healthcare, Biopharmaceuticals
Available Languages
English
Contact
Research Information & Knowledge Hub for additional information on IMD publications